Detection of oseltamivir resistance during treatment of 2009 H1N1 influenza virus infection in immunocompromised patients: Utility of cycle threshold values of qualitative real-time reverse transcriptase PCR

Journal of Clinical Microbiology

Volumn 48, Issue 11, 2010, Pages 4326-4328

  Mehta, Tejal ^a   McGrath, Eric ^b,c   Bheemreddy, Suchitha ^b   Salimnia, Hossein ^b,e   Abdel Haq, Nahed ^b,c   Ang, Jocelyn Y ^b,c   Lum, Lawrence ^b,d   Chandrasekar, Pranatharthi ^b,d   Alangaden, George J ^b,d  

^a Henry Ford Health System Division of Infectious Diseases   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^d KARMANOS CANCER INSTITUTE   (United States)

^e DETROIT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; IMATINIB; MEROPENEM; METHYLPREDNISOLONE; OSELTAMIVIR; PERAMIVIR; RAPAMYCIN; TACROLIMUS; VANCOMYCIN; VORICONAZOLE; ZANAMIVIR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS FUMIGATUS; BLOODSTREAM INFECTION; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC TEST; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG FORMULATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRACORPOREAL PHOTOPHERESIS; FEBRILE NEUTROPENIA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LOWER RESPIRATORY TRACT INFECTION; LUNG ASPERGILLOSIS; LUNG LAVAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NOSE SMEAR; PLEURAL PAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; PUVA; PYROSEQUENCING; QUALITATIVE ANALYSIS; RAPID INFLUENZA DIAGNOSTIC TEST; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; VIRUS DETECTION; VIRUS LOAD; VIRUS RESISTANCE; VIRUS SHEDDING;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OSELTAMIVIR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SPUTUM; TIME FACTORS; VIRAL LOAD; VIRUS SHEDDING;

ORTHOMYXOVIRIDAE;

EID: 78049506507     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01190-10     Document Type: Article

References (11)

1. Birnkrant, D., and E. Cox. 2009. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N. Engl. J. Med. 361(23):2204-2207.
2. Centers for Disease Control and Prevention. 2009. Oseltamavir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb. Mortal. Wkly. Rep. 58(32):893-896.
3. Centers for Disease Control and Prevention. 19 April 2010, accession date. Updated interim recommendations: special considerations for clinicians regarding 2009 H1N1 influenza in severely immunosuppressed patients. http://www.cdc.gov/h1n1flu/immunosuppression/index.htm.
4. Centers for Disease Control and Prevention. 19 April 2010, accession date. Seasonal influenza weekly report. http://www.cdc.gov/flu/weekly/.
5. Gaur, A. H., B. Bagga, S. Barman, R. Hayden, A. Lamptey, J. M. Hoffman, D. Bhojwani, P. M. Flynn, E. Tuomanen, and R. Webby. 2010. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N. Engl. J. Med. 362(1):88-89.
6. Kidd, I. M., J. Down, E. Nastouli, R. Shulman, P. R. Grant, D. C. Howell, and M. Singer. 2009. H1N1 pneumonitis treated with intravenous zanamivir. Lancet 374:1036.
7. Okomo-Adhiambo, M., H. T. Nguyen, K. Sleeman, T. G. Sheu, V. M. Deyde, R. J. Garten, X. Xu, M. W. Shaw, A. I. Klimov, and L. V. Gubareva. 2010. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Res. 85:381-388.
8. Picard, C., M. Silvy, and J. Gabert. 2006. Overview of real-time RT-PCR strategies for quantification of gene rearrangements in myeloid malignancies, p. 27-68. In H. Iland, M. Hertzberg, and P. Marlton (ed.), Myeloid leukemia: methods and protocols. Humana Press, Totawa, NJ.
9. Smith, C. J. 2005. Quantitative real-time PCR, p. 141-142. In M. A. Osborn and C. J. Smith (ed.), Molecular microbial ecology. Taylor & Francis Group, New York, NY.
10. To, K. K., K. H. Chan, I. W. Li, T. Y. Tsang, H. Tse, J. F. Chan, I. F. Hung, S. T. Lai, C. W. Leung, Y. W. Kwan, Y. L. Lau, T. K. Ng, V. C. Cheng, J. S. Peiris, and K. Y. Yuen. 2010. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J. Med. Virol. 82(1):1-7.
11. World Health Organization. 19 April 2010, accession date. CDC pyrosequencing assay to detect H275Y mutation in the neuraminidase of novel A (H1N1) viruses. http://www.who.int/csr/resources/publications/swineflu/NA- DetailedPyrosequencing-20090513.pdf.